Co-Development Financing.

Utilising our network of highly regarded international experts, ERGOMED can offer a comprehensive due diligence service on companies, products, and development and registration strategies, for licensing, partnering, co-development and fund-raising purposes. ERGOMED can also assist companies with clinical development programmes leading to registration or development of out-licensing strategies. ERGOMED has relationships with private and public funding bodies which have an interest in investments in biotech products and companies and will consider formally engaging in partnership with clients developing products where there is a mutual interest and expertise. This engagement could include clinical development, consultancy and/or significant financial support for client companies.

Due Diligence / Biotech product expertise

ERGOMED recognises the increasing needs and demands faced by biotech companies, often with several promising pipeline products, but where restricted resources limit full exploitation of their development potential. In overcoming this, ERGOMED, with its strong team of internal and external experts covering many areas of clinical and non-clinical research and development, can offer a number of solutions. These include due diligence services leading to investment opportunities, partnership with co-development activities, or alternatively ERGOMED consultants may play a direct functional role within the Clinical Development, Program Management or Regulatory departments of client companies.

 

 

 

 

 

 

 

 

 

 
 

 

 

 


© 2007 ERGOMED GmbH - Altenhoferallee 3 - 60438 Frankfurt am Main - Germany - Phone +49 (0) 69 95 11 740 - Fax +49 (0) 69 95 11 74 71
Leagal Information